Compounding: All the Components

NOTE: This session is part of the Live Intensive Studies and Clinical Sessions packages. All attendees may attend these thought-provoking and highly educational sessions. However, if you are board-certified, you must purchase the package(s) for your specialty to receive the recertification assessment and claim the recertification credit.

Rigorous evaluation of products, preparations, and supplies related to sterile compounding is essential, and proactive assessment of supply chain issues is needed to quickly react to shortages and outages of necessary components. Unlike the routine guidance given regarding the use of USP <797> in facility design, personnel training, and environmental monitoring, this session will provide a pragmatic approach to maintaining proper selection, storage, and use of the components needed for sterile compounding. Issues for discussion will include proper selection of manufactured products, selection of equipment and supplies, and monitoring and selection of outsourcing facilities, including compounding pharmacies, nuclear pharmacies, and FDA-registered outsourcing facilities. Scenarios related to recent and potential situations, including those encountered by FDA, state boards of pharmacy, and hospital accreditors will be discussed.

This activity is approved for Board-Certified Sterile Compounding Pharmacist (BCSCP) recertification credit.